Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gennigens

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Revue Medicale De Liege|March 9, 2013
[New treatments for castration-resistant prostate cancer]B Sautois, C Gennigens
Revue Medicale De Liege|September 19, 2012
[Pazopanib (Votrient) in the management of renal cell cancer and soft tissue sarcomas]C Gennigens, G Jerusalem
Revue Medicale De Liege|September 28, 2011
[Trabectedin (ET-743/Yondelis) for treating soft tissue sarcomas and ovarian cancer]C Gennigens, G Jerusalem
Revue Medicale De Liege|January 26, 2013
[Peritoneal carcinomatosis of unknown origin]N Marchal, C Gennigens, G Jerusalem
Revue Medicale De Liege|May 27, 2010
[Everolimus (RAD001/Afinitor) in the treatment of metastatic cell carcinoma]C Gennigens, B Sautois, G Jerusalem
Revue Medicale De Liege|January 14, 2022
[Aseptic loosening after knee mega-prostheses]C Mettlen, C Gennigens, W Kurth
PET Clinics|May 10, 2016
Assessment of Response to Therapy for Bone Metastases: Is it Still a Challenge in Oncology?J Collignon, C Gennigens, G Jerusalem
Revue Medicale De Liege|January 9, 2014
[Clinical case of the month. Ovarian cancer metastasis to the pectoral muscle]A Benoit, G Jerusalem, C Gennigens
Critical Reviews in Oncology/Hematology|January 3, 2006
Insulin-Like Growth Factor (IGF) family and prostate cancerC Gennigens, C Menetrier-Caux, J P Droz
Revue Medicale De Liege|April 7, 2017
[Carcinoma of unknown primary : a not so rare entity]E Gonne, J Collignon, G Jerusalem, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Revue Medicale De Liege|March 9, 2013
[New treatments for castration-resistant prostate cancer]B Sautois, C Gennigens
Revue Medicale De Liege|September 19, 2012
[Pazopanib (Votrient) in the management of renal cell cancer and soft tissue sarcomas]C Gennigens, G Jerusalem
Revue Medicale De Liege|September 28, 2011
[Trabectedin (ET-743/Yondelis) for treating soft tissue sarcomas and ovarian cancer]C Gennigens, G Jerusalem
Revue Medicale De Liege|January 26, 2013
[Peritoneal carcinomatosis of unknown origin]N Marchal, C Gennigens, G Jerusalem
Revue Medicale De Liege|May 27, 2010
[Everolimus (RAD001/Afinitor) in the treatment of metastatic cell carcinoma]C Gennigens, B Sautois, G Jerusalem
Revue Medicale De Liege|January 14, 2022
[Aseptic loosening after knee mega-prostheses]C Mettlen, C Gennigens, W Kurth
PET Clinics|May 10, 2016
Assessment of Response to Therapy for Bone Metastases: Is it Still a Challenge in Oncology?J Collignon, C Gennigens, G Jerusalem
Revue Medicale De Liege|January 9, 2014
[Clinical case of the month. Ovarian cancer metastasis to the pectoral muscle]A Benoit, G Jerusalem, C Gennigens
Critical Reviews in Oncology/Hematology|January 3, 2006
Insulin-Like Growth Factor (IGF) family and prostate cancerC Gennigens, C Menetrier-Caux, J P Droz
Revue Medicale De Liege|April 7, 2017
[Carcinoma of unknown primary : a not so rare entity]E Gonne, J Collignon, G Jerusalem, et al.
Pageof 3